Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 5 May 2025
First Online: 10 June 2025
Competing interests
: S.R.R. may benefit from the licensing or commercial transfer of anti-PEG antibodies developed in the Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan and Kaohsiung Medical School, Kaohsiung, Taiwan.
